Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 355 clinical trials
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-na ve GBM Patients.

A multi-center, open-label, single-arm, phase I/II clinical study is designed to test the safety and immunogenicity of an investigational Dendritic and Glioma Cells Fusion vaccine given with IL-12 for treatment-nave patients after resection of glioblastoma.

white blood cell count
blood cell count
ejection fraction
temozolomide
glioblastoma multiforme
  • 0 views
  • 05 Aug, 2020
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

  • 0 views
  • 14 Mar, 2022
  • 2 locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI test  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 2 locations
Analytics Superset testing, please dont change it (CHXLAS)  

This Phase 2 randomized controlled trial will study the safety, tolerability, and efficacy of Hydroxychloroquine in qualified patients with Alport syndrome. The trial will be open-label, randomized, controlled and will enroll up to 50 patients.

  • 0 views
  • 28 Feb, 2024
  • 1 location
Stress Management and Biological Age in Breast Cancer Patients.RCT  

Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments. This study …

  • 0 views
  • 08 Sep, 2023
  • 1 location
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • 0 views
  • 14 Mar, 2022
  • 5 locations
oo1  

overview

  • 0 views
  • 05 Aug, 2022
  • 1 location
AUTO-REPLY  

AUTO-REPLY

  • 0 views
  • 21 Nov, 2022
  • 2 locations
  • 0 views
  • 01 Aug, 2022
  • 1 location